Why Is Nimodipine So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed nimodipine after a subarachnoid hemorrhage (SAH) and you're struggling to fill the prescription, you are not alone. Nimodipine — sold as the brand Nymalize in oral solution form — has faced stocking challenges at pharmacies across the United States. In 2026, both the oral solution and capsule formulations can be difficult to locate, especially for patients being discharged from the hospital who need to continue their 21-day course at home.

This article explains exactly why nimodipine can be hard to find, what the shortage means for you, and what steps to take to get your prescription filled quickly.

What Is Nimodipine and Why Is It So Important?

Nimodipine is a calcium channel blocker that has been FDA-approved since 1988 to reduce brain damage after an aneurysmal subarachnoid hemorrhage — a type of brain bleed caused by a ruptured aneurysm. After a bleed, blood vessels in and around the brain can go into spasm (called vasospasm), cutting off blood flow to healthy brain tissue. Nimodipine helps prevent this by relaxing those blood vessels.

The standard protocol calls for 60 mg taken every 4 hours for 21 consecutive days. Missing doses or interrupting the course can lead to worsening outcomes, which is why filling this prescription quickly is so critical — it is not a medication patients can simply skip for a few days while waiting for a pharmacy to restock.

Is Nimodipine in a Shortage in 2026?

Yes — at least partially. The FDA has listed Nymalize oral solution (the brand-name liquid formulation of nimodipine) as currently in shortage. This is significant because some patients — particularly those unable to swallow capsules or those using a nasogastric tube — depend on the liquid solution. The oral capsule formulation from generic manufacturers is more widely available, but localized stocking gaps still exist at retail pharmacies.

One major contributor to the shortage is a formulation change by Arbor Pharmaceuticals. The old Nymalize formulations — including 10 mL and 20 mL unit-dose cups and the 473 mL bottle — were discontinued. Arbor now markets Nymalize only as prefilled 5 mL oral syringes (30 mg per syringe at 6 mg/mL). This transition caused supply disruptions that contributed to the ongoing shortage.

Why Do Pharmacies Often Not Stock Nimodipine?

Nimodipine is not a high-volume medication. Because subarachnoid hemorrhage is relatively uncommon, most retail pharmacies do not keep large quantities on hand. Hospitals typically provide the medication during an inpatient stay, but when patients are discharged and need to finish their 21-day course, they may find that their local pharmacy has never even stocked it.

Several other factors compound the availability problem:

• Low demand means low inventory: Community pharmacies prioritize high-turnover drugs. Nimodipine, used for a niche indication, often gets deprioritized.
• Supply chain complexity: Like many generic drugs, nimodipine relies on active pharmaceutical ingredients (APIs) often sourced from overseas manufacturers, making supply fragile.
• Packaging and safety changes: Because of documented deaths from accidental IV injection of nimodipine, manufacturers have changed packaging and delivery systems, which has disrupted supply chains.
• Limited generic manufacturers: While generic capsules exist, there are only a handful of manufacturers in the market, meaning that if one has production issues, availability shrinks quickly.

Is the Nimodipine Capsule Easier to Find Than the Solution?

Generally, yes. Generic nimodipine 30 mg capsules are more widely available than the brand-name Nymalize oral solution, which is currently in FDA shortage. If you have been prescribed the oral solution but are having trouble finding it, talk to your doctor or hospital pharmacist about whether switching to capsules is an option for you.

The ASHP (American Society of Health-System Pharmacists) notes that when Nymalize oral solution is unavailable, the liquid contents of the 30 mg capsules can be withdrawn using an 18-gauge needle and transferred to an oral syringe — but this process requires proper technique and should only be done under pharmacist or medical supervision.

What Should You Do If You Can't Find Nimodipine?

Do not stop taking nimodipine without speaking to your doctor. Discontinuing the medication mid-course after a subarachnoid hemorrhage can have serious consequences. Here are steps to take:

1. Call your hospital's pharmacy first — they may be able to dispense additional supply or transfer your prescription to a specialty pharmacy.
2. Ask your neurologist or neurosurgeon to help — they often have relationships with specialty pharmacies and may know where to source it.
3. Try multiple pharmacies — independent, chain, and specialty pharmacies may have different stock levels.
4. Use medfinder — medfinder contacts pharmacies near you on your behalf to check which ones actually have nimodipine in stock, saving you hours of calling around.

How medfinder Can Help You Locate Nimodipine

When a medication like nimodipine is hard to find, calling pharmacy after pharmacy is exhausting — especially for patients and families already dealing with the stress of a hospitalization. medfinder was built exactly for this situation. You provide your medication, dosage, and zip code. medfinder calls pharmacies in your area to check stock and texts you a list of pharmacies that can fill your prescription.

Read our companion guide: How to Find Nimodipine in Stock Near You (Tools + Tips) for a step-by-step plan to track down your prescription quickly.

Will the Nimodipine Shortage Get Better?

The FDA and ASHP continue to monitor nimodipine availability. The transition to Arbor's new prefilled syringe formulation is ongoing, and generic capsule supply has been stable for most of 2025–2026. However, because this is a low-volume, niche medication with limited manufacturers, it remains vulnerable to supply disruptions. Patients and families should plan ahead whenever possible and maintain open communication with their neurology team.

For the latest on availability, see our Nimodipine Shortage Update for 2026.